Cargando…
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
BACKGROUND: The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding densities, IL-2 concentrations, and bead-to-cell ratios. we f...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254233/ https://www.ncbi.nlm.nih.gov/pubmed/34217218 http://dx.doi.org/10.1186/s12865-021-00435-7 |
_version_ | 1783717687256416256 |
---|---|
author | Ghaffari, Sasan Torabi-Rahvar, Monireh Aghayan, Sajjad Jabbarpour, Zahra Moradzadeh, Kobra Omidkhoda, Azadeh Ahmadbeigi, Naser |
author_facet | Ghaffari, Sasan Torabi-Rahvar, Monireh Aghayan, Sajjad Jabbarpour, Zahra Moradzadeh, Kobra Omidkhoda, Azadeh Ahmadbeigi, Naser |
author_sort | Ghaffari, Sasan |
collection | PubMed |
description | BACKGROUND: The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding densities, IL-2 concentrations, and bead-to-cell ratios. we first expanded the peripheral blood mononuclear cells (PBMCs) of a healthy donor at a range of 20 to 500 IU/mL IL-2 concentrations, 125 × 10(3) to 1.5 × 10(6) cell/mL, and 1:10 to 10:1 B:C (Bead-to-cell) ratios and compared the results. We then expanded the PBMC of three healthy donors using the optimized conditions and examined the growth kinetics. On day 28, CD3, CD4, and CD8 expression of the cell populations were analyzed by flow cytometry. RESULTS: T-cells of the first donor showed greater expansion results in IL-2 concentrations higher than 50 IU/mL compared to 20 IU/mL (P = 0.02). A seeding density of 250 × 10(3) cell/mL was superior to higher or lower densities in expanding T-cells (P = 0.025). Also, we witnessed a direct correlation between the B:C ratio and T-cell expansion, in which, in 5:1 and 10:1 B:C ratios T-cell significantly expanded more than lower B:C ratios. The results of PBMC expansions of three healthy donors were similar in growth kinetics. In the optimized condition, 96–98% of the lymphocyte population expressed CD3. While the majority of these cells expressed CD8, the mean expression of CD4 in the donors was 19.3, 16.5, and 20.4%. CONCLUSIONS: Our methodology demonstrates an optimized culture condition for the production of large quantities of polyclonal T-cells, which could be useful for future clinical and research studies. |
format | Online Article Text |
id | pubmed-8254233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82542332021-07-06 Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy Ghaffari, Sasan Torabi-Rahvar, Monireh Aghayan, Sajjad Jabbarpour, Zahra Moradzadeh, Kobra Omidkhoda, Azadeh Ahmadbeigi, Naser BMC Immunol Research BACKGROUND: The successful ex vivo expansion of T-cells in great numbers is the cornerstone of adoptive cell therapy. We aimed to achieve the most optimal T-cell expansion condition by comparing the expansion of T-cells at various seeding densities, IL-2 concentrations, and bead-to-cell ratios. we first expanded the peripheral blood mononuclear cells (PBMCs) of a healthy donor at a range of 20 to 500 IU/mL IL-2 concentrations, 125 × 10(3) to 1.5 × 10(6) cell/mL, and 1:10 to 10:1 B:C (Bead-to-cell) ratios and compared the results. We then expanded the PBMC of three healthy donors using the optimized conditions and examined the growth kinetics. On day 28, CD3, CD4, and CD8 expression of the cell populations were analyzed by flow cytometry. RESULTS: T-cells of the first donor showed greater expansion results in IL-2 concentrations higher than 50 IU/mL compared to 20 IU/mL (P = 0.02). A seeding density of 250 × 10(3) cell/mL was superior to higher or lower densities in expanding T-cells (P = 0.025). Also, we witnessed a direct correlation between the B:C ratio and T-cell expansion, in which, in 5:1 and 10:1 B:C ratios T-cell significantly expanded more than lower B:C ratios. The results of PBMC expansions of three healthy donors were similar in growth kinetics. In the optimized condition, 96–98% of the lymphocyte population expressed CD3. While the majority of these cells expressed CD8, the mean expression of CD4 in the donors was 19.3, 16.5, and 20.4%. CONCLUSIONS: Our methodology demonstrates an optimized culture condition for the production of large quantities of polyclonal T-cells, which could be useful for future clinical and research studies. BioMed Central 2021-07-03 /pmc/articles/PMC8254233/ /pubmed/34217218 http://dx.doi.org/10.1186/s12865-021-00435-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ghaffari, Sasan Torabi-Rahvar, Monireh Aghayan, Sajjad Jabbarpour, Zahra Moradzadeh, Kobra Omidkhoda, Azadeh Ahmadbeigi, Naser Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy |
title | Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy |
title_full | Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy |
title_fullStr | Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy |
title_full_unstemmed | Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy |
title_short | Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy |
title_sort | optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of t-cell expansion for adoptive immunotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254233/ https://www.ncbi.nlm.nih.gov/pubmed/34217218 http://dx.doi.org/10.1186/s12865-021-00435-7 |
work_keys_str_mv | AT ghaffarisasan optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy AT torabirahvarmonireh optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy AT aghayansajjad optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy AT jabbarpourzahra optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy AT moradzadehkobra optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy AT omidkhodaazadeh optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy AT ahmadbeiginaser optimizinginterleukin2concentrationseedingdensityandbeadtocellratiooftcellexpansionforadoptiveimmunotherapy |